3.685 USD
-0.02 (-0.41%)
ChartMill assigns a Buy % Consensus number of 84% to XFOR. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 8.16. This target is 121.44% above the current price.
- XFOR was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about XFOR.
- In the previous month the buy percentage consensus was at a similar level.
- XFOR was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-05 | Stifel | Maintains | Buy -> Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-29 | Stifel | Maintains | Buy -> Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | Stifel | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-12 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | Stifel | Maintains | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-10 | B. Riley Securities | Maintains | Buy |
| 2023-03-24 | Oppenheimer | Maintains | Outperform |
| 2023-03-22 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-03-22 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-12-12 | Piper Sandler | Initiate | Overweight |
| 2022-11-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-19 | B. Riley Securities | Maintains | Buy |
| 2022-05-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-14 | HC Wainwright & Co. | Maintains | Buy |
X4 PHARMACEUTICALS INC / XFOR FAQ
What is the price target for XFOR stock?
10 analysts have analysed XFOR and the average price target is 8.16 USD. This implies a price increase of 121.44% is expected in the next year compared to the current price of 3.685.
Can you provide the consensus rating for X4 PHARMACEUTICALS INC stock?
The consensus rating for X4 PHARMACEUTICALS INC (XFOR) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for XFOR stock?
The number of analysts covering X4 PHARMACEUTICALS INC (XFOR) is 10.